Cannabinoid
CBD for Social Anxiety Disorder
This trial tests two doses of CBD in willing participants to see if it helps reduce stress and fear by interacting with the body's natural systems. Oral administration of cannabidiol (CBD) has shown to yield a variety of therapeutic benefits among humans, particularly regarding symptoms of anxiety.
Behavioural Intervention
Virtual Reality Therapy for Social Anxiety Disorder
This trial tests if virtual reality videos can help people with social anxiety practice social situations. It targets those who struggle with social interactions and everyday tasks. The therapy works by letting them practice in a virtual world to make real-life interactions less scary. Virtual reality exposure therapy (VRET) has been used in recent years to treat various anxiety disorders, including social phobia.
Behavioral Intervention
ABMT for Social Anxiety Disorder
This trial tests a computer-based therapy called ABMT on kids aged 10-14 with social anxiety. The therapy aims to help them focus less on negative social cues, which may reduce their anxiety. Researchers will compare brain activity and anxiety levels between those who get ABMT and those who do not. Attention Bias Modification Treatment (ABMT) is a novel computer-based treatment for anxiety disorders, proposed as an efficient and accessible psychological therapy.
Behavioral Intervention
Virtual Reality for Public Speaking Anxiety
This trial aims to determine whether people's general level of positivity or their temporary mood affects how well exposure therapy works for speech anxiety. The study will also look at how feelings of self-confidence, hope,
Popular Filters
Trials for SAD Patients
Behavioural Intervention
Fasedienol Nasal Spray for Social Anxiety Disorder
This Phase 3 clinical trial is designed to evaluate the Fasedienol Nasal Spray (fasedienol) for adults that are 18-65 who suffer from symptoms of social anxiety such as nervousness, worry or fear of judgement. In addition, there is an Open Label Extension phase of the study for patients that choose to participate where use of nasal spray for up to 12 months will be assessed.
Behavioral Intervention
Very Brief Exposure for Social Anxiety Disorder
This trial aims to understand how brief exposure to certain stimuli affects young people with social anxiety disorder. The researchers want to develop new ways to help those with social anxiety. They will measure brain activity in response
Behavioural Intervention
BNC210 for Social Anxiety Disorder
This trial aims to see if a one-time dose of BNC210 can help reduce anxiety in adults with social anxiety disorder during a behavioral assessment. They will measure anxiety levels using a scale called the Subject
Behavioral Intervention
Cognitive Behavioral Therapy for Social Anxiety Disorder
This trial aims to assess the effectiveness of a therapy (TBT) for Veterans with anxiety/depression disorders, compared to an existing therapy (DST). Assessments will be done before/during/after treatment & 6mos later.
SSRI
Sertraline + CBT for Social Anxiety Disorder
This trial aims to predict which adults with severe social anxiety will respond to group therapy. If group therapy doesn't work, participants will try one-on-one therapy and a common anxiety medication. The goal is to understand how different treatments affect the brain and improve anxiety.
Trials for Anxiety Patients
Behavioural Intervention
Fasedienol Nasal Spray for Social Anxiety
This Phase 3 clinical trial is designed to evaluate the Fasedienol Nasal Spray (fasedienol) for adults that are 18-65 who suffer from symptoms of social anxiety such as nervousness, worry or fear of judgement. In addition, there is an Open Label Extension phase of the study for patients that choose to participate where use of nasal spray for up to 12 months will be assessed.
Behavioral Intervention
Group Self-Management Support for Anxiety Disorders
This trial aims to study if a virtual group self-management support program can help people with anxiety disorders when added to their usual treatment. The study will evaluate the effectiveness and cost of this program compared to standard
Cognitive Behavioral Therapy
Internet-Based Cognitive Behavioral Therapy for Alcoholism
This trial will test if a cognitive-behavioral treatment for alcohol use disorder that is delivered by computer is effective. The treatment has been shown to work when delivered by a therapist, and if the computer-delivered version is effective, it would be much more accessible to people with this disorder.
Neurostimulation
Trigeminal Nerve Stimulation for Anxiety Disorders
This trial is testing a treatment called trigeminal nerve stimulation, which involves sending electrical signals to a nerve in the face. It aims to help patients with panic disorder, generalized anxiety disorder, and social anxiety disorder. The treatment works by calming brain activity to reduce anxiety symptoms. Trigeminal nerve stimulation (TNS) is a promising strategy in treating diseases of the nervous system, including epilepsy and traumatic brain injury.
Behavioral Intervention
Exposure Therapy for Child Anxiety
This trial will compare the effectiveness of three different types of treatment for anxiety disorders in children and adolescents. The three types of treatment are cognitive behavioral therapy with exposure (CBT), patient-centered telehealth CBT (PCT-CBT; patient-centered telehealth closed as of 5/1/21), and traditional outpatient CBT. The trial will involve 379 participants who will be randomly assigned to one of the three treatment groups. The primary outcome measures will be the changes in the participants' anxiety symptoms, functioning, and quality of life from baseline to follow-up.
Trials With No Placebo
Behavioral Intervention
Very Brief Exposure for Social Anxiety Disorder
This trial aims to understand how brief exposure to certain stimuli affects young people with social anxiety disorder. The researchers want to develop new ways to help those with social anxiety. They will measure brain activity in response
Behavioral Intervention
Cognitive Behavioral Therapy for Social Anxiety Disorder
This trial aims to assess the effectiveness of a therapy (TBT) for Veterans with anxiety/depression disorders, compared to an existing therapy (DST). Assessments will be done before/during/after treatment & 6mos later.
SSRI
Sertraline + CBT for Social Anxiety Disorder
This trial aims to predict which adults with severe social anxiety will respond to group therapy. If group therapy doesn't work, participants will try one-on-one therapy and a common anxiety medication. The goal is to understand how different treatments affect the brain and improve anxiety.
Behavioural Intervention
CBT + HIV Risk Reduction for Social Anxiety
This trial will provide the first efficacy data for a novel and innovative HIV prevention intervention for MSM that combines the most empirically supported treatment for social anxiety disorder, cognitive-behavioural therapy, with HIV risk reduction counselling.
Behavioral Intervention
Respiratory Training vs Interoceptive Exposure for Anxiety
This trial compares three treatments for people with severe anxiety: getting used to scary physical feelings, learning to breathe better, and learning about anxiety. These treatments aim to help those who don't respond well to usual methods or who relapse. The first treatment helps reduce fear of physical sensations, the second helps control breathing to reduce anxiety, and the third provides knowledge about anxiety.
Psychedelic
MDMA-Assisted Psychotherapy for Social Anxiety Disorder
This trial tests MDMA-assisted therapy for people with severe social anxiety who haven't improved with other treatments. MDMA helps reduce fear and makes therapy more effective by making people feel more open and connected. MDMA has been studied for its potential to enhance psychotherapy, particularly in treating social anxiety disorder by improving emotional processing and therapeutic relationships.
View More Related Trials
Frequently Asked Questions
Introduction to social anxiety disorder
What are the top hospitals conducting social anxiety disorder research?
In the realm of mental health research, hospitals and medical centers across the United States are actively exploring ways to help individuals struggling with social anxiety disorder. The Medical Research Network, LLC in New York is one such institution leading the charge with three ongoing clinical trials focused on this condition. Although they have not conducted any previous studies specific to social anxiety disorder, their commitment to finding new treatments offers hope for those affected. Similarly devoted to advancing knowledge in this field is Curavit Clinical Research, located in Boston, which currently has one active trial addressing social anxiety disorder.
Meanwhile, Midwest Research Group based in Saint Charles and Cedar Clinical Research situated in Draper both contribute significantly by conducting a single active clinical trial each for individuals grappling with social anxiety disorder. Both institutions share an unwavering dedication to understanding and treating this challenging condition. Lastly, Ralph H. Johnson VA Medical Center located in Charleston plays a crucial role as well; they are involved in a single active trial targeting social anxiety disorder.
While these hospitals may be at early stages regarding social anxiety disorder research compared to other conditions such as breast cancer mentioned earlier or more prevalent mental health disorders like depression or schizophrenia, their focus on tackling this often debilitating condition highlights a growing recognition of its impact on individuals' lives. The efforts made by these institutions signify promising steps forward towards improved interventions and greater understanding of social anxiety disorder—a significant accomplishment that can pave the way for enhanced treatment options and support systems for those living with it nationwide.
Which are the best cities for social anxiety disorder clinical trials?
When it comes to clinical trials for social anxiety disorder, several cities offer opportunities for individuals seeking innovative treatments. New york, New York stands out with 5 active trials studying interventions like Cannabidiol (CBD) Oral Solution and Cariprazine. Boston, Massachusetts follows closely behind with 3 ongoing studies exploring options such as BVR-100 and Cannabidiol. Additionally, Saint Charles in Missouri, Draper in Utah, and Charleston in South carolina each have one active trial focusing on promising approaches like Transdiagnostic Behavior Therapy and BVR-100 respectively. These cities provide a range of options for individuals looking to participate in groundbreaking research aimed at improving the management of social anxiety disorder.
Which are the top treatments for social anxiety disorder being explored in clinical trials?
Clinical trials are unveiling promising treatments for social anxiety disorder, offering hope to those who struggle with this condition. Among the top contenders is CBT (cognitive behavioral therapy), a proven technique that helps individuals reframe negative thoughts and behaviors associated with social anxiety. Another potential game-changer is ketamine, showing positive outcomes in reducing symptoms of social anxiety disorder. Additionally, virtual reality exposure therapy is gaining recognition as an innovative approach to desensitize individuals to anxiety-provoking situations in a controlled environment. These ongoing clinical trials aim to revolutionize treatment options for social anxiety disorder and improve the lives of millions affected by it.
What are the most recent clinical trials for social anxiety disorder?
The field of social anxiety disorder research continues to advance, offering potential breakthroughs for individuals struggling with this condition. Recent clinical trials have explored the use of cannabidiol (CBD) as a treatment option. Phase 4 trials involving CBD and its effectiveness in managing social anxiety disorder are underway, with promising results emerging from these studies. Additionally, a Phase 2 trial investigated the efficacy of a specific dosage—400mg—of CBD for social anxiety disorder patients, further contributing to our understanding of its therapeutic benefits. These investigations represent significant progress towards developing more effective approaches to address the challenges faced by those living with social anxiety disorder.
What social anxiety disorder clinical trials were recently completed?
Several recent clinical trials have made significant strides in the treatment of social anxiety disorder, providing hope for individuals affected by this debilitating condition. Notably, a trial investigating the effectiveness of Sertraline Hydrochloride was completed in October 2021. Additionally, a study evaluating the efficacy of Cognitive Behavioral Therapy (CBT) concluded in September 2021. These promising advancements highlight the ongoing efforts to find innovative approaches to alleviate symptoms and improve the quality of life for those living with social anxiety disorder.